Rodden Lori A 4
4 · HARTFORD INSURANCE GROUP, INC. · Filed Mar 12, 2026
Research Summary
AI-generated summary of this filing
Hartford (HIG) EVP Lori Rodden Exercises Options, Sells 40,693 Shares
What Happened
Lori A. Rodden, Executive Vice President of Hartford Insurance Group (HIG), exercised a total of 40,693 stock options on March 10, 2026 (30,193 shares at $69.41 and 10,500 shares at $78.28) and sold the same 40,693 shares in open-market transactions that day. Exercise cash paid: $2,917,636 (per filing). Sale proceeds reported: $5,617,537 (two weighted-average sale prices reported). The transactions reflect an immediate sell of the shares received on exercise (cashless-like outcome).
Key Details
- Transaction date: March 10, 2026; Form 4 filed March 12, 2026 (appears timely).
- Options exercised: 30,193 shares @ $69.41 = $2,095,696; 10,500 shares @ $78.28 = $821,940.
- Shares sold: 30,193 shares at a weighted average sale price ~ $138.04 = $4,167,893; 10,500 shares at weighted avg ~ $138.06 = $1,449,644. Total proceeds ≈ $5,617,537.
- Net proceeds (sales minus exercise cost) ≈ $2,699,901.
- Filing notes: weighted-average sale price ranges reported (F1: $138.06–$138.10; F2: $137.98–$138.22). Zero-dollar “Disposed” entries reflect the derivative/option exercise reporting.
- Shares owned after the transactions: not specified in the excerpt of the filing provided.
- Vesting/eligibility: footnotes indicate the options were vested/vested in tranches (e.g., some grants fully exercisable on Feb 23, 2025 and Feb 28, 2026 — see F3–F7).
Context
This is an options exercise followed by immediate open-market sales of the acquired shares (commonly results in a cash-neutral or net-cash-outcome for the insider). Such transactions are routine for employees exercising vested options and selling shares to cover costs or realize gains; they are factual disclosures of insider activity and not, by themselves, a directional market signal.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-03-10$69.41/sh+30,193$2,095,696→ 55,584.617 total - Exercise/Conversion
Common Stock
2026-03-10$78.28/sh+10,500$821,940→ 66,084.617 total - Sale
Common Stock
[F1]2026-03-10$138.06/sh−10,500$1,449,644→ 55,584.617 total - Sale
Common Stock
[F2]2026-03-10$138.04/sh−30,193$4,167,893→ 25,391.617 total - Exercise/Conversion
Stock Option
[F3]2026-03-10−30,193→ 0 totalExercise: $69.41Exp: 2032-02-23→ Common Stock (30,193 underlying) - Exercise/Conversion
Stock Option
[F4]2026-03-10−10,500→ 15,579 totalExercise: $78.28Exp: 2033-02-28→ Common Stock (10,500 underlying)
- 8,894.265
Restricted Stock Units
- 11,399
Stock Option
[F5]Exercise: $95.74Exp: 2034-02-27→ Common Stock (11,399 underlying) - 9,467
Stock Option
[F6]Exercise: $116.41Exp: 2035-02-25→ Common Stock (9,467 underlying) - 9,136
Stock Option
[F7]Exercise: $140.54Exp: 2036-02-24→ Common Stock (9,136 underlying)
Footnotes (7)
- [F1]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $138.06 - $138.10 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $137.98 - $138.22 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
- [F4]The options became fully exercisable on February 28, 2026, the third anniversary of the grant date.
- [F5]One-third of the options became exercisable on February 27, 2025, an additional one-third of the options became exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
- [F6]One-third of the options became exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
- [F7]One-third of the options will become exercisable on February 24, 2027, an additional one-third of the options will become exercisable on February 24, 2028 and the remaining one-third of the options will become exercisable on February 24, 2029, the third anniversary of the grant date.